<DOC>
	<DOCNO>NCT00142103</DOCNO>
	<brief_summary>1 . To characterize tolerability profile subcutaneous ( SC ) CPG 10101 alone , pegylated interferon , ribavirin pegylated interferon ribavirin administer weekly twelve week relapse HCV positive subject . 2 . To assess effect subcutaneous ( SC ) CPG 10101 alone , pegylated interferon , ribavirin pegylated interferon ribavirin serum Hepatitis C Virus ( HCV ) RNA concentration</brief_summary>
	<brief_title>CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus ( HCV ) Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<criteria>HCV positive subject document serum HCV RNA concentration great 1000 IU/mL within 21 day first study treatment . Receipt adequate pegylated IFN plus RVN base therapy minimum 24 week ( pegylated interferon dose &gt; 180 μg weekly &gt; 1.0 μg/kg pegylated interferon weekly least 800 mg RVN daily ) result undetectable HCV RNA concentration treatment subsequent relapse ( HCV RNA concentration detect ) within six month stop therapy . HCV genotype 1 . Adults , 18 + year old . Written Informed Consent . Liver biopsy document change Hepatitis C within 5 year first dose study drug . Adequate bone marrow , liver , renal function demonstrate : hemoglobin &gt; 12 g/dL female &gt; 13 g/dL male WBC &gt; 3,000/mm3 Neutrophils &gt; 1,500/mm3 Platelets &gt; 80,000/mm3 Total bilirubin &lt; 1.6 mg/dL . Direct bilirubin &lt; 1.5 upper limit normal . If indirect bilirubin elevate , Gilbert 's disease must document chart substantiate . Albumin within normal limit ( per central laboratory ) Serum creatinine &lt; upper limit normal per central laboratory calculate creatinine clearance &gt; 100 mL/min ( CockroftGault formula ) . Negative pregnancy test woman child bear potential Females childbearing potential male partner childbearing potential must use two form effective contraception treatment 6 month treatment conclude . Treatment IFN base therapy and/or antiviral therapy within 90 day first dose study drug . ChildPugh Class B C. History psychiatric condition include , limited , psychosis , suicidal ideation , major depression . Subjects mild moderate depression past normal mild Beck Depression Inventory Score prior history suicidal gesture attempt may enrol , Investigator 's opinion , suitable treatment . Significant cardiovascular disease ( e.g. , NYHA class 3 congestive heart failure ; myocardial infarction within past 6 month ; unstable angina ; coronary angioplasty within past 6 month ; uncontrolled atrial ventricular cardiac arrhythmia ) . History immunodeficiency , autoimmune disease , autoimmune hepatitis , allogeneic transplant , preexist autoimmune antibodymediated disease include limited : systemic lupus erythematosus , rheumatoid arthritis , multiple sclerosis , Sjogren 's syndrome , autoimmune thrombocytopenia . Other serious medical condition include , limited : HIV1 , Hepatitis B ( positive HBsAg ) , Cancer , Pregnant , partner pregnant woman , nurse woman , and/or Alcohol drug misuse within 90 day screen Use immunosuppressive dos steroid antimetabolite therapy within 3 month entry study ( inhaled topical corticosteroid permit ) . Receipt vaccine immunoglobulin within 30 day first dose study drug Prior administration oligodeoxynucleotides ( include study medication CPG 10101 ) , ribozymes , know allergy CPG 10101 , interferon , ribavirin excipients Receipt investigational drug therapy within 30 day first dose study drug Any condition , opinion Investigator , may compromise safety compliance subject would preclude subject successful completion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Hepatitis c virus</keyword>
	<keyword>HCV</keyword>
	<keyword>Liver</keyword>
</DOC>